Anisomycin suppresses Jurkat T cell growth by the cell cycle-regulating proteins

Pharmacological Reports

Volumn 65, Issue 2, 2013, Pages 435-444

  Yu, Chunyan ^a   Xing, Feiyue ^a   Tang, Zhengle ^a   Bronner, Christian ^b   Lu, Xijian ^a   Di, Jingfang ^a   Zeng, Shan ^a   Liu, Jing ^a  

^a JINAN UNIVERSITY   (China)

^b INSERM   (France)

Author keywords

Anisomycin; CDK2; ICBP90; Jurkat T cell; P21; P27; P53

Indexed keywords

ANISOMYCIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1C; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P73; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG ACTIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84879400422     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71019-3     Document Type: Article

References (31)

1. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H: Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells, 2004, 9, 131-142.
2. Baus F, Gire V, Fisher D, Piette J, Dulic V: Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J, 2003, 22, 3992-4002.
3. Besson A, Gurian-West M, Chen XY, Kelly-Spratt KS, Kemp CJ, Roberts JM: A pathway in quiescent cells that controls p27(kip1) stability, subcellular localization, and tumor suppression. Genes Dev, 2006, 20, 47-64.
4. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA: Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after g-irradiation. Proc Natl Acad Sci USA, 1999, 96, 1002-1007.
5. Choi JW, Pampeno C, Vukmanovic S, Meruelo D: Characterization of the transcriptional expression of notch-1 signaling pathway members, deltex and hes-1, in developing mouse thymocytes. Dev Comp Immunol, 2002, 26, 575-588.
6. Chung KC, Kim SM, Rhang SG, Lau LF, Gomes I, Ahn YS: Expression of immediate early gene pip92 during anisomycin-induced cell death is mediated by the JNKand p38-dependent activation of Elk1. Eur J Biochem, 2000, 267, 4676-4684.
7. Condorelli G, Trencia A, Vigliotta G, Perfetti A, Goglia U, Cassese A, Musti AM et al.: Multiple members of the mitogen-Activated protein kinase family are necessary for ped/pea-15 anti-Apoptotic function. J Biol Chem, 2002, 277, 11013-11018.
8. Croons V, Martinet W, Herman AG, Timmermans J-P, De Meyer GRY: The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-Activated protein kinase. J Pharmacol Exp Ther, 2009, 329, 856-864.
9. Fang Z, Xing F, Bronner C, Teng Z, Guo Z: Icbp90 mediates the erk1/2 signaling to regulate the proliferation of Jurkat t cells. Cell Immunol, 2009, 257, 80-87.
10. Hopfner R,MousliM, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP et al.: CBP90, a novel human ccaat binding protein, involved in the regulation of topoisomerase II a expression. Cancer Res, 2000, 60, 121-128.
11. Hopfner R, Mousli M, Oudet P, Bronner C: Overexpression of ICBP90, a novel ccaat-binding protein, overcomes cell contact inhibition by forcing topoisomerase II a expression. Anticancer Res, 2002, 22, 3165-3170.
12. Hukkelhoven E, Liu Y, Yeh N, Ciznadija D, Blain SW, Koff A: Tyrosine phosphorylation of p21 facilitates the development of proneural glioma. J Biol Chem, 2012, 287, 38523-38530.
13. Konishi Y, Sato H, Tanaka T: Anisomycin superinduces annexin V mRNA expression through the erk1/2 but not the p38 map kinase pathway. Biochem Biophys Res Commun, 2004, 313, 977-983.
14. Liu G, Lozano G.: P21 stability: Linking chaperones to a cell cycle checkpoint. Cancer Cell, 2005, 7, 113-114.
15. Morgan DO: Principles of cdk regulation. Nature, 1995, 374, 131-134.
16. Mousli M, Hopfner R, Abbady AQ, Monte D, Jeanblanc M, Oudet P, Louis B, Bronner C: ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer, 2003, 89, 120-127.
17. Nitiss JL, Zhou J, Rose A, Hsiung Y, Gale KC, Osheroff N: The bis(naphthalimide) dmp-840 causes cytotoxicity by its action against eukaryotic topoisomerase II. Biochemistry, 1998, 37, 3078-3085.
18. Oliveira CS, Rigon AP, Leal RB, Rossi FM: The activation of erk1/2 and p38 mitogen-Activated protein kinases is dynamically regulated in the developing rat visual system. Int J Dev Neurosci, 2008, 26, 355-362.
19. Pan S, Xing F: Effect of anisomycin on the biologic behavior of Jurkat t cells. Curr Immunol, 2009, 29, 11-18.
20. Park HY, Kim MK, Moon SI, Cho YH, Lee CH: Cell cycle arrest and apoptotic induction in LNCaP cells byMCSC2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway. Cancer Sci, 2006, 97, 430-436.
21. Shieh SY, Ikeda M, Taya Y, Prives C: DNA damageinduced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 1997, 91, 325-334.
22. Smits VAJ, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH: P21 inhibits Thr161 phosphory-lation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem, 2000, 275, 30638-30643.
23. Tang Z, Xing F, Chen D, Yu Y, Yu C, Di J, Liu J: In vivo toxicological evaluation of anisomycin. Toxicol Lett, 2012, 208, 1-11.
24. Walczak K, Turski WA, Rzeski W: Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells. Pharmacol Rep, 2012, 64, 745-750.
25. Xia S, Li Y, Rosen EM, Laterra J: Ribotoxic stress sensitizes glioblastoma cells to death receptor-induced apoptosis: Requirements for c-Jun NH2-terminal kinase and Bim. Mol Cancer Res, 2007, 5, 783-792.13.
26. Xing F, Yu Z, Liu J, Di J, Zeng S, Chen D, Chen L et al.: Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice. J Immunother, 2008, 31, 858-870.
27. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: P21 is a universal inhibitor of cyclin kinases. Nature, 1993, 366, 701-704.
28. Yadav V, Sultana S, Yadav J, Saini N: Gatifloxacin induces s and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PLoS One, 2012, 7, e47796.
29. Yang H, Choi HJ, Park SH, Kim JS, Moon Y: Macrophage inhibitory cytokine-1 (mic-1) and subsequent urokinase-type plasminogen activator mediate cell death responses by ribotoxic anisomycin in hct-116 colon cancer cells. Biochem Pharmacol, 2009, 78, 1205-1213.
30. Yong ST, Wang XF: A novel, non-Apoptotic role for scythe/bat3: a functional switch between the pro-And anti-proliferative roles of p21 during the cell cycle. PLoS One, 2012, 7, e38085.
31. Zhong Y, Krisanapun C, Lee S-H, Nualsanit T, Sams C, Peungvicha P, Baek SJ: Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53. Eur J Cancer, 2010, 46, 3365-3374.